Live from the NIH registry
Studies recruiting near Mobile right now
Top 25 of 168 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Mobile Infirmary Medical Center — Mobile, Alabama (4.5 mi)
· Sponsor: SWOG Cancer Research Network
Observational Study Protocol: LIVER-R
Hepatobiliary Cancers
N/A
Observational 4,490 participants sought
Research Site — Mobile, Alabama (4.5 mi)
· Sponsor: AstraZeneca
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Heart Failure
Phase 3
Interventional 1,500 participants sought
CON-10004 Fairhope, AL Investigational Site — Fairhope, Alabama (16.6 mi)
· Sponsor: Colorado Prevention Center
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
Healthy
Phase 3
Interventional 6,000 participants sought
USA Health Allen Cox Building — Mobile, Alabama (4.5 mi)
· Sponsor: Pfizer
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 1,200 participants sought
USA Mitchell Cancer Institute ( Site 0014) — Mobile, Alabama (4.5 mi)
· Sponsor: Merck Sharp & Dohme LLC
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Southern Cancer Center — Daphne, Alabama (13.7 mi)
· Sponsor: SCRI Development Innovations, LLC
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Phase 3
Interventional 1,530 participants sought
Infirmary Cancer Care ( Site 0001) — Mobile, Alabama (4.5 mi)
· Sponsor: Merck Sharp & Dohme LLC
Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis
Vulvovaginal Candidiases, Vulvovaginal Candidiasis, Genital
Phase 3
Interventional 400 participants sought
Alliance for Multispecialty Research - Mobile — Mobile, Alabama (4.5 mi)
· Sponsor: pH-D Feminine Health LLC
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Mobile Heart USA Health Cardiology Clinic — Mobile, Alabama (4.5 mi)
· Sponsor: Novo Nordisk A/S
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Ganglioneuroblastoma, Nodular, Neuroblastoma
Phase 3
Interventional 478 participants sought
USA Health Strada Patient Care Center — Mobile, Alabama (4.5 mi)
· Sponsor: National Cancer Institute (NCI)
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction
Phase 3
Interventional 5,056 participants sought
Eastern Shore Research Institute — Fairhope, Alabama (16.6 mi)
· Sponsor: Amgen
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
Episodic Migraine
Phase 3
Interventional 450 participants sought
The Center for Clinical Trials - Saraland /ID# 271604 — Saraland, Alabama (10.2 mi)
· Sponsor: AbbVie
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Acute Migraine
Phase 3
Interventional 1,000 participants sought
AMR Mobile — Mobile, Alabama (4.5 mi)
· Sponsor: Kallyope Inc.
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8
Phase 3
Interventional 474 participants sought
Mobile Infirmary Medical Center — Mobile, Alabama (4.5 mi)
· Sponsor: NRG Oncology
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Relapsing Multiple Sclerosis, Multiple Sclerosis
N/A
Observational 2,000 participants sought
TG Therapeutics Investigational Trial Site — Mobile, Alabama (4.5 mi)
· Sponsor: TG Therapeutics, Inc.
Evaluating Clinical Hiatal Hernia Outcomes Using OviTex®
Hiatal Hernia
N/A
Interventional 173 participants sought
University of South Alabama Health — Mobile, Alabama (4.5 mi)
· Sponsor: Tela Bio Inc
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Hematuria - Cause Not Known
N/A
Interventional 1,000 participants sought
Urology Associates of Mobile — Mobile, Alabama (4.5 mi)
· Sponsor: Pacific Edge Limited
PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis
Coronary Artery Disease Risk Factors Multiple, Coronary Artery Disease Progression
Phase 3
Interventional 1,500 participants sought
Cardiology Associates — Mobile, Alabama (4.5 mi)
· Sponsor: Duke University
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Basal Ganglia Germinoma, Diabetes Insipidus
Phase 2
Interventional 240 participants sought
USA Health Strada Patient Care Center — Mobile, Alabama (4.5 mi)
· Sponsor: Children's Oncology Group
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
Multiple Myeloma, Newly Diagnosed Multiple Myeloma
Phase 3
Interventional 520 participants sought
GSK Investigational Site — Mobile, Alabama (4.5 mi)
· Sponsor: GlaxoSmithKline
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Moderate to Severe Chronic Obstructive Pulmonary Disease
Phase 2, Phase 3
Interventional 1,156 participants sought
Pulmonary Associates of Mobile, P.C. — Mobile, Alabama (4.5 mi)
· Sponsor: Pfizer
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Acute Coronary Syndrome
Phase 3
Interventional 2,000 participants sought
Research Site — Mobile, Alabama (4.5 mi)
· Sponsor: DalCor Pharmaceuticals
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System
Persistent Atrial Fibrillation
N/A
Interventional 376 participants sought
Mobile Infirmary Medical Center — Mobile, Alabama (4.5 mi)
· Sponsor: Boston Scientific Corporation
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Atherosclerotic Cardiovascular Disease, Overweight
Phase 3
Interventional 12,800 participants sought
Mobile Heart Specialists PC — Mobile, Alabama (4.5 mi)
· Sponsor: Amgen
A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma
Multiple Myeloma, Secondary Immunodeficiency
Phase 3
Interventional 183 participants sought
Infirmary Health - Diagnostic & Medical Clinic (DMC) — Mobile, Alabama (4.5 mi)
· Sponsor: Takeda